Defining a risk area for tick-borne encephalitis (TBE) in a country where TBE is emerging, the Netherlands, July 2016-October 2020.


Journal

Ticks and tick-borne diseases
ISSN: 1877-9603
Titre abrégé: Ticks Tick Borne Dis
Pays: Netherlands
ID NLM: 101522599

Informations de publication

Date de publication:
03 2022
Historique:
received: 19 05 2021
revised: 20 12 2021
accepted: 27 12 2021
pubmed: 19 1 2022
medline: 22 3 2022
entrez: 18 1 2022
Statut: ppublish

Résumé

TBE is an emerging infectious disease in the Netherlands since July 2016, and risk areas have not been defined yet. Until October 2020 twelve autochthonous cases of TBE have been identified. In six of these cases transmission of TBE virus likely occurred in the Twente region, which therefore is the region with the highest case number and risk of contracting the disease. Here we summarize the Twente cases so far and discuss if the Twente region should be considered a risk-area using criteria of traditional TBE endemic countries, and the public health measures that may accompany such designation.

Identifiants

pubmed: 35042080
pii: S1877-959X(22)00004-8
doi: 10.1016/j.ttbdis.2022.101898
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101898

Informations de copyright

Copyright © 2022. Published by Elsevier GmbH.

Auteurs

Felix Geeraedts (F)

Laboratory for Medical Microbiology and Public Health, Hengelo, the Netherlands. Electronic address: f.geeraedts@labmicta.nl.

Agnes Wertenbroek (A)

Department of Neurology, Ziekenhuis Groep Twente, Almelo/Hengelo, the Netherlands.

Jabke de Klerk (J)

Department of Neurology, Medisch Spectrum Twente, Enschede, the Netherlands.

Jan J Prick (JJ)

Department of Neurology, Ziekenhuis Groep Twente, Almelo/Hengelo, the Netherlands.

Loes J A Reichman (LJA)

Department of Neurology, Ziekenhuis Groep Twente, Almelo/Hengelo, the Netherlands.

Dorine Hess (D)

Laboratory for Medical Microbiology and Public Health, Hengelo, the Netherlands.

Froukje Bosma (F)

Laboratory for Medical Microbiology and Public Health, Hengelo, the Netherlands; Public Health Service, Twente, the Netherlands.

Johan Reimerink (J)

Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.

Ben Skidmore (B)

Public Health Service, Twente, the Netherlands.

Gozewijn D Laverman (GD)

Department of Internal Medicine, Ziekenhuis Groep Twente, Almelo/Hengelo, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH